abstract |
The invention relates to crystal forms A and B of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride (Org 12962), to methods for the preparation of those crystal forms and to pharmaceutical compositions comprising crystal form B useful in the treatment of depression, anxiety, obesity, or urinary incontinence. |